Ignite Creation Date:
2024-05-06 @ 4:26 PM
Last Modification Date:
2024-10-26 @ 2:10 PM
Study NCT ID:
NCT04989322
Status:
RECRUITING
Last Update Posted:
2021-12-08
First Post:
2021-07-26
Brief Title:
Pembrolizumab Lenvatinib and Chemotherapy After TKIs in NSCLC
Sponsor:
Dr Joanne CHIU
Organization:
The University of Hong Kong
Organization Data
Organization:
The University of Hong Kong
Class:
OTHER
Study ID:
475-0708-MT-Lung
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Dr Joanne CHIU
Lead Sponsor Class:
OTHER
Responsible Party:
Dr Joanne CHIU
Responsible Party Title:
Assistant Professor
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
The University of Hong Kong
Old Name:
None
Old Organization:
None